Catalyst Funds Management Pty Ltd Has $1.12 Million Stock Holdings in Cigna Group $CI

Catalyst Funds Management Pty Ltd boosted its position in shares of Cigna Group (NYSE:CI) by 9.0% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,400 shares of the health services provider’s stock after purchasing an additional 280 shares during the period. Catalyst Funds Management Pty Ltd’s holdings in Cigna Group were worth $1,124,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of CI. Brighton Jones LLC grew its stake in shares of Cigna Group by 9.3% in the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock valued at $1,032,000 after buying an additional 318 shares in the last quarter. J.W. Cole Advisors Inc. grew its position in Cigna Group by 113.2% in the first quarter. J.W. Cole Advisors Inc. now owns 4,237 shares of the health services provider’s stock worth $1,394,000 after acquiring an additional 2,250 shares in the last quarter. GW&K Investment Management LLC increased its stake in shares of Cigna Group by 16.9% during the 1st quarter. GW&K Investment Management LLC now owns 276 shares of the health services provider’s stock worth $91,000 after purchasing an additional 40 shares during the last quarter. PFG Advisors raised its holdings in shares of Cigna Group by 5.2% during the 1st quarter. PFG Advisors now owns 2,750 shares of the health services provider’s stock valued at $905,000 after purchasing an additional 135 shares in the last quarter. Finally, Proficio Capital Partners LLC raised its holdings in shares of Cigna Group by 130.2% during the 1st quarter. Proficio Capital Partners LLC now owns 1,989 shares of the health services provider’s stock valued at $654,000 after purchasing an additional 1,125 shares in the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have commented on CI shares. Wolfe Research lowered their target price on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 15th. Leerink Partners decreased their price target on Cigna Group from $300.00 to $270.00 in a research note on Friday, October 31st. Wells Fargo & Company cut their price objective on Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a research note on Wednesday, November 5th. Weiss Ratings restated a “hold (c)” rating on shares of Cigna Group in a report on Thursday, November 13th. Finally, Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, November 8th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Cigna Group currently has an average rating of “Moderate Buy” and a consensus target price of $334.05.

Cigna Group Price Performance

Shares of NYSE:CI opened at $272.11 on Thursday. The company has a market cap of $72.69 billion, a price-to-earnings ratio of 14.85, a PEG ratio of 0.88 and a beta of 0.44. The business has a 50 day moving average price of $287.96 and a 200 day moving average price of $299.78. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, topping analysts’ consensus estimates of $7.64 by $0.19. The company had revenue of $69.57 billion during the quarter, compared to analyst estimates of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same period in the previous year, the company earned $7.51 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Research analysts predict that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be issued a dividend of $1.51 per share. The ex-dividend date is Thursday, December 4th. This represents a $6.04 annualized dividend and a dividend yield of 2.2%. Cigna Group’s payout ratio is presently 26.64%.

Insider Transactions at Cigna Group

In related news, CEO David Cordani acquired 4,134 shares of the business’s stock in a transaction dated Monday, November 3rd. The stock was acquired at an average price of $241.88 per share, with a total value of $999,931.92. Following the completion of the transaction, the chief executive officer owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. This represents a 2.69% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction dated Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the sale, the insider directly owned 51,182 shares in the company, valued at approximately $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.70% of the stock is currently owned by corporate insiders.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.